Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.27B
Revenue (ttm)	1.77B
Net Income (ttm)	268.05M
Shares Out	177.68M
EPS (ttm)	1.50
PE Ratio	8.51
Forward PE	7.33
Dividend	0.36 (2.85%)
Ex-Dividend Date	Mar 24, 2025

Volume	322,000
Average Volume	436,265
Open	12.92
Previous Close	12.85
Day's Range	12.55 - 13.07
52-Week Range	9.20 - 17.61
Beta	0.36
RSI	49.28
Earnings Date	May 7, 2025

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital produc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.